Cadrenal Therapeutics, Inc. (CVKD)
NASDAQ: CVKD · Real-Time Price · USD
7.11
-0.26 (-3.53%)
At close: Dec 19, 2025, 4:00 PM EST
7.15
+0.04 (0.56%)
After-hours: Dec 19, 2025, 7:47 PM EST

Cadrenal Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22
152610-
Market Cap Growth
-36.31%168.05%--
Enterprise Value
11211-
Last Close Price
7.1114.4911.10-
PB Ratio
5.353.471.25-
P/TBV Ratio
5.403.471.25-
Debt / Equity Ratio
--0.00-0.11
Quick Ratio
2.863.7510.210.02
Current Ratio
3.023.7710.270.55
Return on Equity (ROE)
-468.03%-140.78%-780.59%-
Return on Assets (ROA)
-209.23%-73.49%-102.62%-
Return on Capital (ROIC)
-298.29%-90.41%-340.35%-
Return on Capital Employed (ROCE)
-536.60%-147.30%-99.20%529.80%
Earnings Yield
-97.47%-41.24%-86.73%-
FCF Yield
-80.18%-28.51%-36.67%-
Buyback Yield / Dilution
-47.19%-35.59%-70.99%-
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q